Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-06
2007-03-06
Spivack, Phyllis (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
10489224
ABSTRACT:
The disclosure concerns an injectable composition of paclitaxel, more particularly, an injectable composition of paclitaxel having excellent anticancer effect comprising solubilizer such as polyoxyl hydrogenated castor oil, anhydrous ethanol and stabilizer such as N-acetyl amino acid. The injectable compositions of paclitaxel provide a medical effect higher than that of the known compositions showing not only a lower toxicity but also superior solubility of paclitaxel and stability at room temperature, thus enabling venous injection by having fine particles.
REFERENCES:
patent: 5403858 (1995-04-01), Bastard et al.
patent: 5504102 (1996-04-01), Agharkar et al.
patent: 5733888 (1998-03-01), Carver et al.
patent: 5922754 (1999-07-01), Burchett et al.
patent: 6046230 (2000-04-01), Chung et al.
patent: 583955 (1994-02-01), None
patent: 645145 (1995-03-01), None
patent: WO 94/12198 (1994-06-01), None
patent: WO 99/49848 (1999-10-01), None
David R. Lide, ed., CRC Handbook of Chemistry and Physics, 86th Edition, Taylor and Francis, Boca Raton, FL, 2006.
BASF, Cremophor RH Grade Technical Leaflet, May 1992. Accessed from <http://www.basf-korea.co.kr/02—products/04—finechemicals/document/cosmetic/tech/surfactants/down.asp?file=cremophorrhgrades.pdf> on Apr. 20, 2006.
Alkan-Onyuksel, H. et al., “A Mixed Micellar Formulation Suitable for the Parenteral Administration of Taxol,”Pharmaceutical Research11(2): 206-212, Feb. 1994.
Sharma and Straubinger, “Novel taxol formulations: preparation and characterization of taxol-containing liposomes,”Pharm. Res.11(6): 889-896, 1994.
Sharma, D. et al., “Novel Taxol® Formulation: Polyvinylpyrrolidone Nanoparticle-Encapsulated Taxol® for Drug Delivery in Cancer Therapy,”Oncology Research8(7/8): 281-286, 1996.
Patent Abstracts of Japan, JP 01-116082, May 9, 1989. Available from http://www.jpo.go.jp.
Patent Abstracts of Japan, JP 06-206815, Jul. 26, 1994. Available from http://www.jpo.go.jp.
Kim Kye-Hyun
Lee Sang-Heon
Lee Woo-Young
Anderson James D.
Choongwae Pharma Corporation
Seed IP Law Group PLLC
Spivack Phyllis
LandOfFree
Injectable composition of paclitaxel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable composition of paclitaxel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable composition of paclitaxel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772776